Meta Pixel

News and Announcements

Debunking the Top 3 Myths About Raising Capital

  • Published August 31, 2023 1:19AM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

Raising capital is a journey filled with challenges and opportunities. As a founder, director, or CEO, understanding the process is crucial to successfully navigate this journey. Today, let’s debunk three common myths about raising capital and provide valuable insights based on real-world experiences.

YouTube player

Myth 1: Raising Capital Only Takes 2-3 Months

The first myth is that raising capital only takes two to three months. In reality, it can take anywhere from six months to 18 months. Capital raising takes time and often involves a significant amount of behind-the-scenes work. It’s not uncommon for companies to work on a capital raise for up to a year before closing the deal.

Myth 2: Advisors Use Sophisticated Analytical Tools

The second myth is that corporate advisors and investment banks use sophisticated analytical tools for their transactions. However, many companies and advisors use simple tools like Excel spreadsheets and emails for their transactions. The use of analytics in the capital raising process is crucial, and companies should have visibility over who is involved and what is happening inside the deal room.

Myth 3: VCs are the Main Investors

The third myth is that venture capitalists (VCs) are the main investors in this space. While VCs play a significant role, they are not the only investors. High net worth family offices and industry participants are often the main investors in this space. There are many different investment groups that operate outside of the VC structure.

In conclusion, raising capital is a journey that involves different stages, each with its own set of challenges. Understanding these stages can help you better navigate the capital raising process and increase your chances of success. Remember, every stage of your business, from ideation to pre-IPO, presents unique opportunities to attract investment and drive growth. Embrace these challenges, learn from them, and keep moving forward on your capital raising journey.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now